Related Experiment Video
Updated: Jul 17, 2026
Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
Published on: April 3, 2026
Immune profiling shows limited systemic changes in children with autism after autologous cord blood transfusion
Yik-Lam Cho1,2,3, Zoe Mei Yun Tay1, Nicholas Kim Huat Khoo1,2
1Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Introduction:
Autism spectrum disorder (ASD or autism) is a neurodevelopmental condition characterized by social difficulties and restricted, repetitive behaviors, and is a leading cause of morbidity in children and adolescents. Immune dysregulation, including neuroinflammation, brain autoantibodies, and altered adaptive responses, has been implicated in autism pathophysiology. To address these immune alterations, autologous cord blood transfusion has been proposed as a therapy, given its abundance of immune regulatory cells and lack of rejection risk.
Methods:
Using multi-parametric mass cytometry, we profiled the peripheral blood mononuclear cells from children with autism at pre-transfusion and 6 months post-transfusion to assess the effects of this intervention on effector and regulatory subsets.
Results:
Our results showed that transfusion did not increase regulatory T or B cells. However, there was a decrease in CD4+ Central Memory (CM) T cells and memory B cells 6 months after transfusion that are not attributable to changes related to an increase in age.
Discussion:
Our findings suggest that autologous cord blood transfusion does not appear to provide major systemic immunoregulatory benefits in children with autism.
